Contribution of molecular chiral mesoporous silica nanoparticles in delivering drugs with chiral recognition ability
Source abstract
Abstract
Among massive study of mesoporous silica nanoparticles, molecular chiral mesoporous silica nanoparticles (MC-MSN) enjoy great interests recently as it may exert special functions in chiral environment. To elucidate its potential abilities as drug carriers, the present work focused on its prominent advantage of chiral recognition in adsorbing and delivering drug molecules, which mainly covered molecular recognition of racemic drugs and chiral delivery of achiral drug by triggering chiral responses in biological environment. The result turned out that the loading capacity of L-alanine was 1.56-fold higher than that of DL-alanine, reminding that MC-MSN had effective molecular recognition function due to its chirality. Furthermore, the peak area ratio of levorotary ofloxacin/dextral ofloxacin from loaded ofloxacin was obviously higher than ofloxacin, confirming that MC-MSN can molecularly recognize levorotary drug. After loading poorly water-soluble drug indometacin (IMC) into MC-MSN, the carrier delivered IMC with improved anti-inflammation effect based on its chiral recognition effect.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Analytical Chemistry and Chromatography · Lipid Membrane Structure and Behavior · Drug Transport and Resistance Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (29)
Show source-provided references
1. Trends in the development of chiral drugs10.1016/S1359-6446(03)02904-0 ↗
2. Recent advances on the use of cyclodextrins in the chiral analysis of drugs by capillary electrophoresis10.1016/j.chroma.2016.08.029 ↗
3. A novel method for assessing inhibition of ibuprofen chiral inversion and its application in drug discovery10.1016/j.ijpharm.2006.11.006 ↗
4. The cooperative effect of both molecular and supramolecular chirality on cell adhesion10.1002/anie.201801462 ↗
5. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging10.1016/j.colsurfb.2013.04.009 ↗
6. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity10.1016/j.colsurfb.2016.02.009 ↗
7. Evaluation of mesoporous silica nanoparticles for oral drug delivery – current status and perspective of MSNs drug carriers10.1039/C7NR05762H ↗
8. Silica/organosilica cross-linked block copolymer micelles: a versatile theranostic platform10.1039/C6CS00495D ↗
9. Ordered mesoporous materials for bioadsorption and biocatalysis10.1021/cm0485658 ↗
10. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study10.1016/j.ejpb.2011.12.002 ↗
11. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers10.1016/j.ejps.2015.02.008 ↗
12. Mesoporous silica formulation strategies for drug dissolution enhancement: a review10.1517/17425247.2016.1100165 ↗
13. Basic evaluation of typical nanoporous silica nanoparticles in being drug carrier: structure, wettability and hemolysis10.1016/j.msec.2016.12.122 ↗
14. Cellular level evaluation and lysozyme adsorption regulation of bimodal nanoporous silica10.1016/j.msec.2017.03.096 ↗
15. Core-shell hierarchical mesostructured silica nanoparticles for gene/ chemo-synergetic stepwise therapy of multidrug-resistant cancer10.1016/j.biomaterials.2017.04.028 ↗
16. Chiral mesoporous silica: Chiral construction and imprinting via cooperative self-assembly of amphiphiles and silica precursors10.1039/C0CS00002G ↗
17. Supramolecular chiral transcription and recognition by mesoporous silica prepared by chiral imprinting of a helical micelle10.1002/anie.200900303 ↗
18. Preparation of chiral mesoporous materials with helicity perfectly controlled
19. Synthesis of chiral mesoporous silica by using chiral anionic surfactants10.1016/j.micromeso.2007.01.018 ↗
20. Gold Nanorod@Chiral mesoporous silica core−shell nanoparticles with unique optical properties10.1021/ja312327m ↗
21. Synthesis of chiral mesoporous silicas with oligo(saccharide) surfaces and their use in separation of stereoisomers10.1016/j.jcis.2011.03.017 ↗
22. Synthesis of amino group functionalized monodispersed mesoporous silica10.1016/j.micromeso.2010.10.025 ↗
23. Formation pathways of mesoporous silica nanoparticles with dodecagonal tiling
24. Biomimetic synthesized chiral mesoporous silica: structures and controlled release functions as drug carrier10.1016/j.msec.2015.05.039 ↗
25. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: Influence of pore size on release rate10.1016/j.msec.2013.08.014 ↗
26. Jing Superiority of Chiral-handed mesoporous silica nanoparticles in delivering Nimesulide10.1016/j.mseb.2021.115161 ↗
27. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment10.1016/j.msec.2020.111526 ↗
28. Mesoporous silica nanospheres as nanocarriers for poorly soluble drug itraconazole with high loading capacity and enhanced bioavailability10.1016/j.micromeso.2020.110389 ↗
29. Mesoporous silica particles based on complex micelles of poorly water-soluble compounds. One simple step to multidrug carriers10.1016/j.micromeso.2021.110911 ↗